An egg protein made without hens just went national — and precision fermentation is having its grocery-aisle moment

Food & Farming 4 min 7 sources

The Every Company is quadrupling output after its animal-free egg white landed in Walmart and Target, orders up 550%. Behind it: a quiet shift where scarce food proteins get brewed by microbes instead of pulled from animals. Plus grocery prices cool, China restarts soybean buying, and cheap cameras start spotting crop disease.

Key takeaways

An animal-free egg protein made by microbes went national at Walmart and Target, and its maker is quadrupling output — a sign precision fermentation is moving from novelty to the grocery aisle.
Precision fermentation breaks the old link between a scarce food protein and the animal that carries it: you brew it in a tank instead of raising more livestock, and tanks scale faster than herds.
Beyond the lab, shoppers got mild relief as grocery prices cooled, and US soybean farmers got their biggest buyer, China, back.

The most interesting food story this week isn’t a shortage — it’s a factory being told to get four times bigger.

An egg protein without the hen goes national

The Every Company, which makes egg-white protein without any chickens, said in mid-June it is quadrupling its manufacturing capacity [1]. The reason is demand: orders for its flagship product, an egg-white protein called OvoPro, grew 550% in the first four months of 2026 versus all of 2025, after the product rolled out nationally at Walmart and Target [1].

OvoPro is made by precision fermentation — you give a microbe the genetic instructions for a specific protein, feed it sugar in a tank, and it brews that protein the way brewer’s yeast makes alcohol. The result here is ovalbumin, the same protein that makes up most of an egg white, used to bind and enrich baked goods, bars, snacks and pasta [1]. It is shelf-stable for two years and needs no refrigeration [1].

The number that tells you this is real is not the science — it’s the plumbing. Every’s manufacturing partner, Huvepharma, runs a fermentation site in Bulgaria with more than 9 million litres of tank capacity, infrastructure already used by companies in over 100 countries [1]. “We do not just scale processes — we industrialize them,” said the site’s chief, Anguel Jeliazkov [1]. Every’s own chief executive, Arturo Elizondo, framed the demand plainly: the food industry wants egg proteins “without the supply chain challenges endemic in the global egg supply chain” [1] — a nod to the avian-flu outbreaks and price spikes that have battered real eggs.

The same trick, a scarcer protein

Every isn’t alone. The same week, the trade press reported that lactoferrin — a protein found in milk and human breast milk, prized for immune and iron-transport roles and long expensive because you can only extract tiny amounts from dairy — is “breaking into the mainstream” as precision fermentation makes it scalable, animal-free and more affordable [2].

Here’s the mechanism worth carrying: for decades, if you wanted a scarce protein, you had to get more of the animal that carried it. Precision fermentation breaks that link. You don’t find more of the scarce thing — you teach a microbe to make it. That turns a farming problem (more hens, more cows) into a manufacturing one (more tanks), and manufacturing scales in ways herds don’t.

Prices cool at the till

For shoppers, the near-term news was mild relief. US grocery prices barely moved in May: food-at-home inflation rose just 0.1% month over month, cooling from a hotter April, and was up 2.7% over the year [3]. That was a bright spot inside an otherwise rough report — overall inflation jumped 0.5% for the month and 4.2% over the year, its fastest annual pace since 2023, driven mostly by an energy price spike [3]. Groceries, at least, held steady while the wider basket climbed.

Farmers get a buyer back

American soybean growers got their biggest customer back. China — the largest buyer of US soybean exports — is placing orders again after a purchasing freeze ended with a trade agreement last autumn [4]. Prices are up slightly from 2025 and the weather is cooperating, lifting grower morale, though planting costs remain high and, USDA data shows, there is “still a long way” to a full recovery [4].

The longer game sits underneath that trade. A study in Nature Food modelled how China could grow more of its own soybeans instead of importing them [6]. China’s self-sufficiency fell from full independence in 1961 to 17% by 2022, and would slide to 12% by 2050 if nothing changed [6]. No single fix does much — but rehabilitating salt-damaged land, approving gene-edited soybeans, and shifting diets, combined, could lift self-sufficiency to 74% by 2030 [6]. The payoff isn’t only Chinese: freeing up that soy could feed 1.89 billion more people worldwide while sparing tropical forests from being cleared for new cropland [6].

Cheaper eyes on the crop

Two quieter science stories point the same way — toward doing more with what a field already has. German researchers built a low-cost camera rig that photographs maize plants and uses a trained model to spot smut, a fungal disease, with near-perfect accuracy in the lab [5]. The point isn’t the accuracy — it’s the “low-cost” and the open, build-it-yourself design [5]. Disease detection that once needed an expert eye starts becoming something a cheap machine can do at scale.

And at the most basic level of all, researchers edited Rubisco, the enzyme every plant uses to pull carbon from the air — famously slow and inefficient [7]. Editing a few of its building blocks produced plants with larger leaves and more mass than unedited ones at normal air [7]. It is early, lab-stage work. But Rubisco sits inside every leaf on Earth, so even a small efficiency gain is a very large lever.

02 · Lesson · why it matters

Why the invention is the easy part

A new food is dreamed up in a lab but made real in a factory — and the slow, unglamorous scale-up, not the eureka, is where abundance actually comes from.

The news was a factory, not a discovery

An egg-white protein made without a single chicken went national this week. It is easy to read that as a science story — clever microbes, brewed protein, the future arriving. But look at what actually changed. The protein itself has existed for years. What changed in June was that a company was told to make its factory four times bigger, because a store shelf filled up faster than the tanks could keep pace.

That gap — between a thing existing and a thing you can actually buy — is the whole lesson. And it runs through far more of the food you eat than the science ever does.

Anyone can make it once

Making a protein one time, in a lab, is the part that gets the headline. It is also the easy part.

The hard part is making it a million times. By the tanker-load. Cheaply enough to compete with the old version. Stable enough to sit on a shelf for two years without a fridge. Consistent enough that every batch behaves the same in a factory that bakes ten thousand loaves an hour. None of that is discovery. All of it is grind — engineering, plumbing, logistics, contracts.

We tend to think a new food is real the moment someone proves it can be done. It isn’t. It is real the moment it can be done boringly — the same way, every day, at a price a normal person pays without thinking. Most inventions never cross that line. The ones that reach your table are the ones that got boring.

The leverage sits with whoever owns the tanks

Here is the part the headline hides. The company with the clever science did not build the factory. It rented one.

The egg protein is brewed in Bulgaria, in fermentation tanks owned by a different company — infrastructure already used by firms in more than a hundred countries. The inventor has the recipe. The tank-owner has the capacity. And when demand jumps, it is the tank-owner who decides how fast the new food can grow. “We don’t just scale processes,” their chief said. “We industrialize them.”

Sit with that. In a world where anyone with the right knowledge can design a protein, the scarce thing is no longer the idea. It is the ability to make the idea at scale. Whoever owns the tanks, the reactors, the industrial capacity — they hold the lever. This arrangement serves them, and it also serves the inventor who gets to grow and the eater who gets a cheaper, steadier supply. All three can be true at once. But if you want to know who really controls how fast the food system changes, don’t watch the labs. Watch who owns the factories.

New things ride on old capacity

Notice, too, what the tanks were built for. Not this. That Bulgarian site was making things for animal health and industry long before it ever brewed an egg protein. The new food did not build its own world from scratch. It moved into a world someone else had already paid to build.

This is almost always how it works. Insulin has been brewed by engineered microbes for forty years; the new food proteins are walking through a door that medicine opened. A breakthrough rarely arrives on empty ground. It arrives on top of decades of unglamorous capacity — pipes, tanks, standards, supply chains — laid down for other reasons by people whose names never make the story. The eureka gets remembered. The infrastructure it stood on gets forgotten.

You are downstream of the boring part

This is not a distant story. It reaches your plate.

The reason a company wanted an egg protein without hens was blunt: real eggs keep getting hammered by bird-flu outbreaks and price spikes. A protein brewed in a tank doesn’t catch the flu. So the quiet payoff of all that industrial grind is a food supply with one less thing that lurches when a virus hits a flock — a steadier shelf, a calmer price, for you. You will never see the tank. You will only feel its absence when the thing it protects against doesn’t happen.

And that is the trap in how we watch progress. We cheer the inventor and overlook the factory. We remember the discovery and forget the decade of scale-up that turned it into something a person could afford. But the abundance that actually reaches a table was mostly built at the boring end — the reactor, the retail deal, the box that ships without ice — by people we will never thank.

What any one seat can see

The story we like to tell about food is a story of clever ideas. The story that actually feeds people is a story of capacity — who can make how much, how cheaply, how reliably, on whose machines. Both are true. But they are not equally visible, and the visible one is the smaller one.

None of us stands where we can see the whole of it. The shopper sees a price. The inventor sees a recipe. The tank-owner sees a schedule. The farmer whose egg market just shifted sees a threat, or a relief, depending on the day. Each holds one real piece and mistakes it for the shape of the thing. The machine that puts food on a billion tables was built, and is still being built, mostly out of parts no single person watches — and knowing that is less a reason to feel clever than a reason to hold your read of it loosely.

03 · Lab · your turn

The Scale-Up

Spend your effort turning a proven food invention into something people can buy, and feel that the boring scale-up — not the recipe — is where reach comes from.

04 · Hope · carry this

The reason a scarce protein can now be brewed in a tank is that thousands of people spent years on the unglamorous work of making it ordinary — and that quiet, shared competence is exactly how a food system slowly becomes harder to break.